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Background: With the emergence of strains resistant to conventional antibiotics, it is important to carry studies
using alternative methods to control these microorganisms causing important infections, such as the use of
products of plant origin that has demonstrated effective antimicrobial activity besides biocompatibility. Therefore,
this study aimed to evaluate the antimicrobial activity of plant extracts of Equisetum arvense L., Glycyrrhiza glabra L.,
Punica granatum L. and Stryphnodendron barbatimam Mart. against Staphylococcus aureus, Staphylococcus
epidermidis, Streptococcus mutans, Candida albicans, Candida tropicalis, and Candida glabrata, and to analyze the
cytotoxicity of these extracts in cultured murine macrophages (RAW 264.7).
Methods: Antimicrobial activity of plant extracts was evaluated by microdilution method based on Clinical and
Laboratory Standards Institute (CLSI), M7-A6 and M27-A2 standards. The cytotoxicity of concentrations that
eliminated the microorganisms was evaluated by MTT colorimetric method and by quantification of
proinflammatory cytokines (IL-1β and TNF-α) using ELISA.
Results: In determining the minimum microbicidal concentration, E. arvense L., P. granatum L., and S. barbatimam Mart.
extracts at a concentration of 50 mg/mL and G. glabra L. extract at a concentration of 100 mg/mL, were effective against
all microorganisms tested. Regarding cell viability, values were 48% for E. arvense L., 76% for P. granatum L, 86% for
S. barbatimam Mart. and 79% for G. glabra L. at the same concentrations. About cytokine production after stimulation
with the most effective concentrations of the extracts, there was a significant increase of IL-1β in macrophage cultures
treated with S. barbatimam Mart. (3.98 pg/mL) and P. granatum L. (7.72 pg/mL) compared to control (2.20 pg/mL) and a
significant decrease of TNF-α was observed in cultures treated with G. glabra L. (4.92 pg/mL), S. barbatimam Mart.
(0.85 pg/mL), E. arvense L. (0.83 pg/mL), and P. granatum L. (0.00 pg/mL) when compared to control (41.96 pg/mL).
Conclusions: All plant extracts were effective against the microorganisms tested. The G. glabra L. extract exhibited least
cytotoxicity and the E. arvense L. extract was the most cytotoxic.
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Herbal drugs have been used since ancient times as rem-
edies for the treatment of a variety of diseases. Despite
advances in modern medicine, plants still make an import-
ant contribution to health care [1]. Herbal extracts or
essential oils prepared from medicinal plants contain dif-
ferent compounds with numerous biological activities
confirmed by in vitro and in vivo studies, such as antibac-
terial, antifungal, antiviral, antiprotozoal, anthelminthic,
antiseptic, anti-inflammatory, antitumor, antioxidative,
antiallergic, anticonvulsant, antidepressant, contraceptive,
antimutagenic, analgesic, and diuretic properties [2-4].
Some compounds are used for the treatment of diabetes,
nervous system disorders such as Alzheimer’s disease,
dental diseases, male infertility, and erectile dysfunction
[5], among other therapeutic properties.
Studies have demonstrated the antimicrobial activity
of Equisetum arvense L. (Equisetaceae), Glycyrrhiza
glabra L. (Fabaceae), Punica granatum L. (Punicaceae),
and Stryphnodendron barbatimam Mart. (Leguminosae)
[6-11]. However, knowledge of the toxicity of these ex-
tracts is scarce. Scientific knowledge of the antimicro-
bial properties of plant species may contribute to the
development of drugs against microorganisms of med-
ical interest, particularly in dentistry. In this respect, the
environmental conditions of the oral cavity favor infec-
tion and inflammation caused by opportunistic micro-
organisms such as Staphylococcus spp., Streptococcus
spp., and Candida spp.
Staphylococcus aureus can cause endodontic infections,
parotid gland infections, mandibular osteomyelitis, mu-
cositis, apical abscesses, and postoperative complications
after dental implant placement [12-14]. Moreover,
methicillin-resistant S. aureus (MRSA) have emerged as
causative agents of serious infections in hospitals [15].
Staphylococcus epidermidis is an important agent of
hospital-acquired infections and possesses pathogenic
properties such as adhesion to implanted materials and
biofilm formation [16]. Microorganisms organized in
biofilms are more resistant to antimicrobial agents and
components of host immunity [17,18].
Streptococcus mutans is an important etiological agent
of dental caries in humans that attaches to the tooth
surface and forms a biofilm [13,14]. For this purpose, the
microorganism produces glucosyltransferases and synthe-
sizes an adherent and water-insoluble glucan from sucrose
that permits it to adhere firmly to the tooth surface [19].
The colonization of the oral cavity with S. mutans depends
on factors such as salivary flow, saliva buffering capacity,
and presence of salivary immunoglobulins [20].
Biofilm formation is an important virulence factor for
Candida species because it increases resistance to anti-
fungal therapy [21,22]. C. albicans is the most patho-
genic species in humans and is commonly identified indental prostheses and oral candidiasis. These yeasts
colonize the oral mucosa, tongue and palate. Oral, vaginal
or systemic candidiasis is a common infection in immuno-
compromised patients that can be fatal [13,14,21,23,24].
Alternative microbiological control measures that are
suitable for use in humans are of the utmost importance in
view of the emergence of antimicrobial-resistant strains.
Therefore, the present study evaluated the effectiveness of
herbal extracts of E. arvense L., G. glabra L., P. granatum
L. and S. barbatimam Mart. against clinical strains of
Staphylococcus spp., S. mutans and Candida spp. In
addition, the cytotoxic effects of the extract were investi-
gated based on cell viability and cytokine production
(interleukin 1β [IL-1β] and tumor necrosis factor α [TNF-
α]) in cultured mouse macrophages (RAW 264.7).Methods
The study was approved by the Ethics Committee of the
São José dos Campos Dental School, UNESP (protocol
008/2012-PA/CEP).Antimicrobial activity
Dry powders of E. arvense L., G. glabra L., P. granatum L.
and S. barbatimam Mart. were purchased from the Oficina
de Ervas (Ribeirão Preto, São Paulo, Brazil) and the extracts
were prepared in propylene glycol (200 mg/mL).
Nine clinical strains and reference strains (ATCC) of S.
aureus (ATCC 6538), S. epidermidis (ATCC 12228), S.
mutans (ATCC 35688), C. albicans (ATCC 18804), C.
tropicalis (ATCC 13803) and C. glabrata (ATCC 90030)
obtained from the Laboratory of Microbiology and Im-
munology, Institute of Science and Technology, were
used. The clinical strains were identified after isolation
from the oral cavity of patients with pulmonary tubercu-
losis. A total of 60 strains were tested.
Bacteria and yeast were cultured in brain-heart infusion
(BHI – Himedia, Mumbai, Maharashtra, India) and
Sabouraud-dextrose broth (Himedia), respectively, for 24 h
at 37°C. S. mutans was incubated under microaerophilic
conditions (5% CO2). The microbial suspensions were pre-
pared in sterile saline (0.9% NaCl) at a standard concentra-
tion of 5 × 105 cells/mL for bacteria and 1 × 103 to 5 × 103
cells/mL for yeast.
The microdilution method was performed according to
NCCLS guidelines [25,26], changes name to Clinical and
Laboratory Standards Institute (CLSI). For this purpose,
10 dilutions of the plant extracts (100 to 0.19 mg/mL)
were prepared in Mueller-Hinton medium (Himedia) for
bacteria and in RPMI 1640 medium (Himedia) plus MOPS
buffer (Sigma Aldrich, St. Louis, Missouri, USA), pH 7.0 ±
0.1, for yeast. Next, 5 μL of the bacterial suspension or
100 μL of the yeast suspension was inoculated into each
well of 96-well plates (TPP, Trasadingen, Schaffhausen,











S. aureus 50 100 25 25
S. epidermidis 50 100 25 12.5
S. mutans 25 100 12.5 3.13
C. albicans 50 50 50 50
C. tropicalis 50 50 50 50
C. glabrata 50 50 50 50
*Ten strains of each microbial species were evaluated.
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37°C (under microaerophilic conditions for S. mutans).
After determination of the Minimum Inhibitory Con-
centration (MIC), 100 μL of this concentration and one
above and one below this concentration were seeded
onto BHI or Sabouraud-dextrose agar plates to deter-
mine the Minimum Microbicidal Concentration (MMC)
of the extracts. After 48 h of incubation, the MMC was
determined on plates that showed no growth of colonies.
The results are reported as the percentage of strains
inhibited at each concentration of the plant extract.
Cell culture
Mouse macrophages (RAW 264.7) obtained from the
Rio de Janeiro Cell Bank - Associação Técnico Científica
Paul Ehrlich (APABCAM - Rio de Janeiro, RJ, Brazil)
were cultured routinely in Dulbecco’s Modified Eagle
Medium (DMEM - LGC Biotechnology, Cotia, SP,
Brazil) supplemented with 10% fetal bovine serum (FBS –
Gibco, USA) at 37°C in a 5% CO2 atmosphere. Viable cells
were counted by the Trypan blue (0.5%, Sigma-Aldrich, St.
Louis, MO, USA) exclusion method.
Cytotoxicity testing (MTT assay)
For the experimental and positive control groups, 8 ×
103 viable cells/well were seeded in 96-well plates
(Nunc, Kamstrupvej, Roskilde, Denmark) and the plates
were incubated for 24 h at 37°C. Next, the cell cultures
were exposed to 200 μL of the serial dilutions of the plant
extracts according to the concentrations obtained in the
microbiological test and incubated for 24 h. At the end of
exposure, the cell culture medium was discarded and cell
survival was determined by the MTT assay [MTT - (3-
(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium brom-
ide; Sigma-Aldrich].
The plates were washed with phosphate-buffered saline
(PBS - Cultilab, Campinas, São Paulo, Brazil) and 100 μL
MTT solution (0.5 mg/mL in PBS) was added to each well.
After incubation for 1 h, MTT solution was removed and
100 μL dimethyl sulfoxide (DMSO - Sigma-Aldrich) was
added to each well. The plates were incubated for 10 min
and then shaken on a shaker for an additional 10 min. Op-
tical densities were measured in a multi-well spectropho-
tometer (Bio-Tek, Winooski, Vermont, USA) at 570 nm.
The optical density values obtained for cultures exposed
to the extracts were normalized to untreated control cul-
tures (corresponding to 100%).
The results of the cytotoxicity tests were analyzed by
ANOVA and the Tukey test (P ≤ 0.05) using the BioEstat
5.0 software.
Quantification of IL-1β and TNF-α
For analysis of cytokine production, 1 × 106 RAW264.7
cells were seeded in 24-well plates and incubated for24 h at 37°C. Next, the cell cultures were exposed to
concentrations of the plant extracts that were the most
effective in the microbiological test. After incubation for
24 h, the supernatant was collected from each well and
frozen at −18°C.
The levels of IL-1β and TNF-α in the supernatants
were determined by enzyme-linked immunosorbent
assay (ELISA) using the DuoSet ELISA Development
System for IL-1β (DY401) and TNF-α (DY410) ((R&D
Systems, Minneapolis, Minnesota, USA) according to
manufacturer instructions. Optical densities were read on
a microplate spectrophotometer at 450 nm and converted
into IL-1β and TNF-α concentrations (pg/mL) using the
GraphPad Prism 5.0 program.
The results were analyzed by ANOVA and the Tukey
test (P ≤ 0.05) using the BioEstat 5.0 software.Results
The antimicrobial activity of the plant extracts is shown in
Table 1. The E. arvense L. extract, at a concentration of 50
mg/mL, eliminated 100% of S. aureus, S. epidermidis, C.
albicans, C. tropicalis, and C. glabrata strains. At a con-
centration of 25 mg/mL, this extract eliminated 100% of S.
mutans. The MMC of the G. glabra L. extract was 100
mg/mL for S. aureus, S. epidermidis and S. mutans, and
50 mg/mL for yeast (C. albicans, C. tropicalis, and C.
glabrata). The P. granatum L. extract presented an MMC
of 25 mg/mL for S. aureus and S. epidermidis, 12.5 mg/mL
for S. mutans, and 50 mg/mL for yeast. The widest vari-
ation in MMC was observed for the S. barbatimam Mart.
extract, with an MMC of 3.13 mg/mL for S. mutans, 12.5
mg/mL for S. epidermidis, 25 mg/mL for S. aureus, and
50 mg/mL for yeasts.
Cytotoxicity of the plant extracts was evaluated in cul-
tured macrophages by the MTTassay. The highest cell sur-
vival rates were observed for cultures treated with G.
glabra L., P. granatum L. and S. barbatimam Mart. The
group treated with the E. arvense L. extract exhibited the
lowest survival rate (<50%) (Table 2).
Table 2 Percentage of cell viability (± SD) after treatment












100 - 79 ± 6.18B - -
50 48 ± 5.29B 52 ± 2.96C 76 ± 3.10B 86 ± 4.05B
25 45 ± 1.08B - 57 ± 5.24C 70 ± 4.96 C
12,5 - - 57 ± 3.70C 65 ± 4.91C
3,13 - - - 72 ± 6.27C
Control 100A 100A 100A 100A
Different superscript letters indicate statistically significant differences (P < 0.05).
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increase of IL-1β production in cultures treated with the
P. granatum L. and S. barbatimam Mart. extracts when
compared to the control group. No difference in IL-1β
production was observed between cultures treated with
the E. arvense L. and G. glabra L. extracts and the con-
trol group (Table 3).
All extracts significantly reduced the production of TNF-
α when compared to the control group, with complete
inhibition of TNF-α production in the P. granatum L.-
treated group (Table 3).
Discussion
The present study evaluated the antimicrobial activity of
plant extracts not only against reference strains (ATCC),
but also against clinical isolates since differences in anti-
microbial susceptibility exist between the same species iso-
lated from different patients as demonstrated by the
present results. The four extracts exerted microbicidal ac-
tivity against six microbial species. However, the MMC
varied according to the extract and its concentration used
and according to bacterial or fungal species studied.
The S. mutans isolates showed high sensitivity to the
E. arvense L. extract, with a concentration of 25 mg/mL
inhibiting the growth of all strains. At a concentration ofTable 3 Levels of IL-1β and TNF-α (mean ± standard
deviation, pg/mL) in macrophage culture supernatants
after exposure to plant extracts (100 mg/mL for G. glabra
L. and 50 mg/ml for E. arvense L., P. granatum L. and
S. barbatimam Mart.)
Plant extract Cytokine production (pg/mL)
IL-1β TNF-α
E. arvense L. 1.32 ± 1.37A 0.83 ± 2.86B
G. glabra L. 1.99 ± 1.46A 4.92 ±1.46B
P. granatum L. 7.72 ±1.13C 0.00B
S. barbatimam Mart. 3.98 ± 1.40B 0.85 ± 2.93B
Control 2.20 ± 2.11A 41.96 ± 10.53A
Different superscript letters indicate statistically significant differences (P < 0.05).50 mg/mL, E. arvense L. was effective against all Staphylo-
coccus spp. and Candida spp. isolates. The antimicrobial
activity of E. arvense L. can be attributed to the presence
of various compounds such as the phenolic monoterpene
thymol, capable inhibit the growth of microorganisms
[8,27]. It was reported that concentrations of E. arvense L.
hydromethanolic extracts presented a dose-dependent ac-
tivity in S. aureus, at 10–1000 mg/mL, showing a total
elimination at 1000 mg/mL [28]. According to Radulovic
et al. [27] the essential oil of E. arvense L. also showed
activity against S. aureus and C. albicans strains, in agree-
ment with our study, yet it was effective against Gram-
negative bacteria Klebsiella pneumoniae, Pseudomonas
aeruginosa, Salmonella enteritidis, Escherichia coli, and
against Aspergillus niger. In vitro tests also demonstrated
the inhibitory effect of E. arvense L. hydroethanolic extract
against Neisseria gonorrhoeae [29].
The G. glabra L. extract inhibited the growth of all bac-
terial strains studied at a concentration of 100 mg/mL. In
contrast, fungal growth was inhibited at a concentration of
less than 50 mg/mL, demonstrating that Candida spp.
were more sensitive to the extract than the bacterial
strains. Antifungal activity of this plant was attributed to
the presence of glabridin, hispaglabridin B [30] and 18β-
glycyrrhetinic acid [9]. Glabridin exhibiting inhibitory ac-
tivity against C. albicans strain and inhibited the growth
of this yeast mutant strain resistant to amphotericin B, ny-
statin and clotrimazole [30]. This compound also showed
inhibitory effect on the growth of S. aureus strains sensi-
tive and resistant to methicillin, showing MIC at 12.5 mg/
mL [31]. The 18β-glycyrrhetinic acid caused inhibitory ef-
fect for C. albicans at concentrations of 50 and 100 mg/
mL [9]. Clinical and reference strains of this yeast was also
proven their susceptibility to the extract of G. glabra
L. prepared in different solvents as ethanol, ethyl acetate,
and hexane [32]. According to our study, Hwang et al.
[33] also found the antibacterial extract G. glabra L regard
to S. mutans. Statti et al. [34] collected G. glabra L. from
different regions of Calabria, Italy, and verified an inhibi-
tory effect on bacteria and fungi, and this biological activ-
ity varied due to differences in the chemical composition
of this plant obtained from different sites.
The P. granatum L. extract completely inhibited the
growth of S. mutans, Staphylococcus spp. and Candida
spp. at concentrations of 12.5, 25 and 50 mg/mL, respect-
ively. Thus, S. mutans showed high sensitivity to the ex-
tract, whereas Candida spp. exhibited low sensitivity to
P. granatum L., requiring higher concentrations for
growth inhibition. Rosas-Piñón et al. [35] studying the me-
dicinal plants from a Mexico region used by local people
to treat dental diseases such as toothache, dental caries,
periodontal disease and gingivitis, found the antimicrobial
activity of 47 plant species on Porphyromonas gingivalis
and S. mutans. According to our study, the authors
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L extract, compared to P. gingivalis, showing lower inhibi-
tory concentrations of growth. Thus, it is believed that this
higher sensitivity of streptococcal is related to its cell com-
position. Products based on P. granatum L., as commer-
cial sauces and juices also showed antimicrobial activity
against natural microbiota of vegetables such as lettuce,
chives and parsley, as well as on S. aureus and E. coli that
was inoculated on these plants [36]. Our results are in
agreement with Abdollahzadeh et al. [37], which verified
that P. granatum L. extract was effective on oral oppor-
tunistic pathogens such as S. aureus, S. epidermidis,
S. mutans and C. albicans. Also, Fawole et al. [38] showed
that P. granatum L. extract was effective on S. aureus, and
this extract also presented antimicrobial activity against
K. pneumoniae and E. coli. Some studies have also been
proven the effectiveness of P. granatum L. against MRSA,
Listeria monocytogenes, Bacillus subtilis, S. enteritidis and
Yersinia enterocolitica [39]. The bactericidal activity of this
plant is due to the presence of tannins and punicalagins
[40,41]. A paste based on the extract of P. granatum
L. [42] was produced and applied on wounds created in
guinea pigs and their potential healing was confirmed with
total regression of the wound in 20 days, and also effect-
ively control the microbiota of the wound. In vitro tests
have demonstrated the antimicrobial activity of this ex-
tract on S. aureus, P. aeruginosa, E. coli, K. pneumoniae,
Salmonella anatum, S. typhimurium, S. pneumoniae,
C. albicans, C. glabrata, and A. rubrum Trichopyton niger.
Vasconcelos et al. [7] also used a gel based on P. granatum
L. extract to control S. mutans, S. sanguis, S. mitis and
C. albicans, alone or associated with each other, and it has
shown inhibition of adhesion of these microorganisms on
the glass surface. By inhibiting the adherence of S. mutans
other species also have their adhesion impaired, since this
streptococci fail to provide the support to anchor these
pathogens; e.g., C. albicans on the tooth surface [43].
The S. barbatimam Mart. extract exerted microbicidal
activity at different concentrations, which were 3.13 mg/
mL for S. mutans, 12.5 mg/mL for S. aureus, and 25
mg/mL for S. epidermidis. However, only the concentra-
tion of 50 mg/mL was effective against the Candida spe-
cies tested. The results of our study demonstrate that S.
mutans was the most sensitive specie to S. barbatimam
Mart. extract, and C. albicans was less sensitive, agreeing
with the study by Pereira et al. [44], which the extract of
Stryphnodendron spp. also had lower and higher MMC
against S. mutans and C. albicans, respectively. The ex-
tract of Stryphnodendron spp. produced in aqueous and
ethyl-acetate fractions showed significant antifungal activ-
ity against clinical isolates of C. albicans, C. parapsilosis
and C. tropicalis, and revealed that the presence of tannins
affected the integrity of the cell wall of Candida, a factor
that contributes to decreased adhesion to host cellsand germ-tube formation, besides affecting the budding
process and stimulate phagocytosis [6].
The present study also analyzed the cytotoxicity of the E.
arvense L., G. glabra L., P. granatum L. and S. barbatimam
Mart extracts in macrophage cultures (RAW 264.7) using
the most effective concentrations obtained in the micro-
biological test. Except for P. granatum L., there are no
studies in the literature investigating the cytotoxicity of
these plants by the methods used here. After exposure
for 24 h to G. glabra L., at concentrations of 100 and
50 mg/mL, reduced cell survival by 79% (± 6.18) and 52%
(± 2.96), respectively. The viability of cells treated with
P. granatum L. at a concentration of 50 mg/mL was 76%
(± 3.10), whereas the percentage of surviving cells was 57%
(± 5.24) and 57% (± 3.70) at concentrations of 25 and 12.5
mg/mL, respectively. The percentage of surviving cells was
86% (± 4.05), 70% (± 4.96), 65% (± 4.91), and 72% (± 6.27)
for macrophages treated with S. barbatimam Mart. at con-
centrations of 50, 25, 12.5 and 3.13 mg/mL, respectively.
Cell viability was less than 50% only in the groups treated
with E. arvense L., i.e., 48% (± 5.29) at 50 mg/mL and 45%
(± 1.08) at 25 mg/mL. It has been demonstrated reduction
in cell viability after 24 h exposure to antimicrobials used
in endodontic therapy such as ciprofloxacin hydrochloride,
clindamycin hydrochloride, and metronidazole, with these
drugs, showing dose-dependent cytotoxicity [45]. In the
present study, cell viability was significantly higher in the
groups treated with higher concentrations of G. glabra L.,
P. granatum L. and S. barbatimam Mart. when compared
to the groups treated with lower concentrations.
The cytotoxicity of the plant extracts was also investi-
gated by quantifying the production of IL-1β and TNF-α in
cell cultures (RAW 264.7) after 24-h exposure to concen-
trations of the extracts that were most effective against the
microorganisms tested. No significant difference in the
production of IL-1β was observed between cultures treated
with E. arvense L. (1.32 ± 1.37 pg/mL) and G. glabra
L. (1.99 ± 1.46 pg/mL) and the control group (2.20 ± 2.11
pg/mL). In contrast, production of this cytokine was sig-
nificantly higher in cultures treated with S. barbatimam
Mart. (3.98 ± 1.40 pg/mL) and P. granatum L. (7.72 ± 1.13
pg/mL). The production of TNF-α was significantly lower
in cultures treated with E. arvense L. (0.83 ± 2.86 pg/mL),
G. glabra L. (4.92 ± 1.46 pg/mL) and S. barbatimam Mart.
(0.85 ± 2.93 pg/mL) when compared to the group not stim-
ulated with the extracts (41.96 ± 10.53 pg/mL). The
P. granatum L. extract completely inhibited the synthesis
of TNF-α. Thus, it was observed that the basal levels of
TNF-α were higher than those of IL-1β. This behavior also
was shown in other studies [46,47].
The study of the cytotoxicity and antimicrobial activity
of natural products such as plant extracts is important
for the clinical application of these compounds in differ-
ent areas of health care. For example, in dentistry,
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tions and even toothpastes with antimicrobial activity
could be developed that are safe for use in humans.
However, animal studies and subsequent clinical trials
are needed to confirm the safety of these products.
Conclusion
In conclusion, the E. arvense L., G. glabra L. P. granatum
L. and S. barbatimam Mart. extracts exerted microbicidal
activity against all Staphylococcus spp., S. mutans and Can-
dida spp. strains tested. The G. glabra extract exhibited
least cytotoxicity and the E. arvense extract was the most
cytotoxic.
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